Abstract
Purpose
To present a single-center experience on pituitary tumor apoplexy and a review of literature focusing on predisposing and precipitating factors.
Methods
Clinical presentation of our series of cases. Contemporary published literature is also reviewed.
Results
The definition of this syndrome has not been consistent although now the majority of authors agree to definite it as an acute condition caused by hemorrhage or infarction of a pre-existing pituitary adenoma. Different predisposing and precipitating factors have been described in literature; among these antithrombotic and anticoagulant drugs, seem to play relevant roles. The clinical cases observed in our clinic confirm these data and suggest a probable association between elderly patients taking anticoagulant therapy and pituitary apoplexy adenoma.
Conclusion
Pituitary tumor apoplexy remains a challenging disease in relation to difficulties in correct diagnosis and thus in appropriate treatment. Antithrombotic/anticoagulant therapy may have an important role as precipitating factor. When a pituitary disorder is known, great care should be taken in the prescription of anticoagulant therapy.
Similar content being viewed by others
References
Dubuisson AS, Beckers A, Stevenaert A (2007) Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg 109:63–70. doi:10.1016/j.clineuro.2006.01.006
Arafah BM, Salti IS (1978) Partial hypopituitarism following septic peritonitis with shock. Arch Intern Med 138:1272–1273
Dash RJ, Gupta V, Suri S (1993) Sheehan’s syndrome: clinical profile, pituitary hormone responses and computed sellar tomography. Aust N Z J Med 23:26–31
Verrees M, Arafah BM, Selman WR (2004) Pituitary tumor apoplexy: characteristics, treatment, and outcomes. Neurosurg Focus 16:E6
Turgut M, Ozsunar Y, Başak S et al (2010) Pituitary apoplexy: an overview of 186 cases published during the last century. Acta Neurochir (Wien) 152:749–761. doi:10.1007/s00701-009-0595-8
Nawar RN, AbdelMannan D, Selman WR, Arafah BM (2008) Pituitary tumor apoplexy: a review. J Intensive Care Med 23:75–90. doi:10.1177/0885066607312992
Moller-Goede DL, Brandle M, Landau K et al (2011) Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome. Eur J Endocrinol 164:37–43. doi:10.1530/EJE-10-0651
Ranabir S, Baruah MP (2011) Pituitary apoplexy. Indian J Endocrinol Metab 15(Suppl 3):S188–S196. doi:10.4103/2230-8210.84862
Semple PL, Webb MK, de Villiers JC, Laws ER (2005) Pituitary apoplexy. Neurosurgery 56:65–72 (discussion 72–73)
Wildemberg LEA, Neto LV, Niemeyer P et al (2012) Association of dengue hemorrhagic fever with multiple risk factors for pituitary apoplexy. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 18:e97–e101. doi:10.4158/EP11341.CR
Carosi G, Malchiodi E, Ferrante E et al (2015) Hypothalamic-pituitary axis in non-functioning pituitary adenomas: focus on the prevalence of isolated central hypoadrenalism. Neuroendocrinology. doi:10.1159/000430815
Onesti ST, Wisniewski T, Post KD (1990) Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients. Neurosurgery 26:980–986
Murad-Kejbou S, Eggenberger E (2009) Pituitary apoplexy: evaluation, management, and prognosis. Curr Opin Ophthalmol 20:456–461. doi:10.1097/ICU.0b013e3283319061
Endoh M, Wakai S, Iouh S, Nagai M (1994) Massive intraventricular hemorrhage from prolactinoma during bromocriptine therapy: case report. No Shinkei Geka 22:661–664
Sibal L, Ball SG, Connolly V et al (2004) Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary 7:157–163. doi:10.1007/s11102-005-1050-3
Maïza JC, Bennet A, Thorn-Kany M et al (2004) Pituitary apoplexy and idiopathic thrombocytopenic purpura: a new case and review of the literature. Pituitary 7:189–192. doi:10.1007/s11102-005-1760-6
Kelion AD, Shahi M, Bell JA (1997) An unusual neurological problem in a patient admitted for acute myocardial infarction. Postgrad Med J 73:669–670
Fuchs S, Beeri R, Hasin Y et al (1998) Pituitary apoplexy as a first manifestation of pituitary adenomas following intensive thrombolytic and antithrombotic therapy. Am J Cardiol 81:110–111
Semple PL, Jane JA, Laws ER (2007) Clinical relevance of precipitating factors in pituitary apoplexy. Neurosurgery 61:956–961. doi:10.1227/01.neu.0000303191.57178.2a (discussion 961–962)
Audia S, Popitean L, Camus A et al (2006) An unusual complication of anticoagulation therapy in an elderly patient: pituitary apoplexy with remission of acromegaly. J Am Geriatr Soc 54:1798–1800. doi:10.1111/j.1532-5415.2006.00933.x
Nagarajan DV, Bird D, Papouchado M (2003) Pituitary apoplexy following anticoagulation for acute coronary syndrome. Heart Br Card Soc 89:10
Kumar V, Kataria R, Mehta VS (2011) Dengue hemorrhagic fever: a rare cause of pituitary tumor hemorrhage and reversible vision loss. Indian J Ophthalmol 59:311–312. doi:10.4103/0301-4738.82002
Motivala S, Gologorsky Y, Kostandinov J, Post KD (2011) Pituitary disorders during pregnancy. Endocrinol Metab Clin North Am 40:827–836. doi:10.1016/j.ecl.2011.08.007
Schrupp Berg HL, Edlow JA (2007) Post-partum pituitary apoplexy: a case report. Intern Emerg Med 2:311–314. doi:10.1007/s11739-007-0084-0
Mizuno T (2011) Pituitary apoplexy with third cranial nerve palsy after off-pump coronary artery bypass grafting. Interact CardioVasc Thorac Surg 13:240–242. doi:10.1510/icvts.2011.268854
Mukhida K, Kolyvas G (2007) Pituitary apoplexy following cardiac surgery. Can J Neurol Sci J Can Sci Neurol 34:390–393
Acar F, Mertol T (2004) Pituitary apoplexy following laparascopic cholocystectomy. Acta Neurochir (Wien) 146:1275–1276. doi:10.1007/s00701-004-0321-5
Brennan CF, Malone RG, Weaver JA (1956) Pituitary necrosis in diabetes mellitus. Lancet Lond Engl 271:12–16
Cardoso ER, Peterson EW (1984) Pituitary apoplexy: a review. Neurosurgery 14:363–373
Reid RL, Quigley ME, Yen SS (1985) Pituitary apoplexy. A review. Arch Neurol 42:712–719
Weisberg LA (1977) Pituitary apoplexy. Association of degenerative change in pituitary ademona with radiotherapy and detection by cerebral computed tomography. Am J Med 63:109–115
Biousse V, Newman NJ, Oyesiku NM (2001) Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry 71:542–545
Chapman AJ, Williams G, Hockley AD, London DR (1985) Pituitary apoplexy after combined test of anterior pituitary function. Br Med J Clin Res Ed 291:26
Arita K, Tominaga A, Sugiyama K et al (2006) Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg 104:884–891. doi:10.3171/jns.2006.104.6.884
Tan TM, Caputo C, Mehta A et al (2007) Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report. J Med Case Rep 1:74. doi:10.1186/1752-1947-1-74
Dupuy O, Bordier L, Galzin A et al (2010) Uncommon complication of anticoagulant therapy: pituitary hemorrhage. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne 31:e1–e2. doi:10.1016/j.revmed.2010.01.005
Mou C, Han T, Zhao H et al (2009) Clinical features and immunohistochemical changes of pituitary apoplexy. J Clin Neurosci Off J Neurosurg Soc Australas 16:64–68. doi:10.1016/j.jocn.2008.02.012
Randeva HS, Schoebel J, Byrne J et al (1999) Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) 51:181–188
Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJL (2004) Acute management of pituitary apoplexy—surgery or conservative management? Clin Endocrinol (Oxf) 61:747–752. doi:10.1111/j.1365-2265.2004.02162.x
da Motta LA, de Mello PA, de Lacerda CM et al (1999) Pituitary apoplexy. Clinical course, endocrine evaluations and treatment analysis. J Neurosurg Sci 43:25–36
McFadzean RM, Doyle D, Rampling R et al (1991) Pituitary apoplexy and its effect on vision. Neurosurgery 29:669–675
Bills DC, Meyer FB, Laws ER et al (1993) A retrospective analysis of pituitary apoplexy. Neurosurgery 33:602–608 (discussion 608–609)
Lubina A, Olchovsky D, Berezin M et al (2005) Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir (Wien) 147:151–157. doi:10.1007/s00701-004-0413-2 (discussion 157)
Samada K, Shiraishi H, Aoyagi J, Momoi MY (2009) Cerebral hemorrhage associated with sildenafil (Revatio) in an infant. Pediatr Cardiol 30:998–999. doi:10.1007/s00246-009-9460-z
Alpsan MH, Bebek N, Ciftci FD et al (2008) Intracerebral hemorrhage associated with sildenafil use: a case report. J Neurol 255:932–933. doi:10.1007/s00415-008-0618-z
Gazzeri R, Neroni M, Galarza M, Esposito S (2008) Intracerebral hemorrhage associated with use of tadalafil (Cialis). Neurology 70:1289–1290. doi:10.1212/01.wnl.0000308939.16685.b6
Mehdizadeh M, Hosseini H, Yazdchi T, Farahangiz S (2008) Visual field defect as a presenting sign for hemorrhagic stroke caused by sildenafil. Indian J Ophthalmol 56:159–160
Hellstrom WJG (2006) Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra). Neurology 66:293–294. doi:10.1212/01.wnl.0000204244.93406.5a (author reply 293–294)
McGee HT, Egan RA, Clark WM (2005) Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra). Neurology 64:1095–1096. doi:10.1212/01.WNL.0000154468.11834.41
Buxton N, Flannery T, Wild D, Bassi S (2001) Sildenafil (Viagra)-induced spontaneous intracerebral haemorrhage. Br J Neurosurg 15:347–349
Monastero R, Pipia C, Camarda LK, Camarda R (2001) Intracerebral haemorrhage associated with sildenafil citrate. J Neurol 248:141–142
Ballard SA, Gingell CJ, Tang K et al (1998) Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 159:2164–2171
McHugh J, Cheek DJ (1998) Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations. Am J Crit Care Off Publ Am Assoc Crit-Care Nurses 7:131–140 (quiz 141–142)
Muthukumar N, Rossette D, Soundaram M et al (2008) Blindness following pituitary apoplexy: timing of surgery and neuro-ophthalmic outcome. J Clin Neurosci Off J Neurosurg Soc Australas 15:873–879. doi:10.1016/j.jocn.2007.08.010
Maccagnan P, Macedo CL, Kayath MJ et al (1995) Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab 80:2190–2197. doi:10.1210/jcem.80.7.7608278
Gruber A, Clayton J, Kumar S et al (2006) Pituitary apoplexy: retrospective review of 30 patients–is surgical intervention always necessary? Br J Neurosurg 20:379–385
Rajasekaran S, Vanderpump M, Baldeweg S et al (2011) UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf) 74:9–20. doi:10.1111/j.1365-2265.2010.03913.x
Takeda N, Fujita K, Katayama S et al (2010) Effect of transsphenoidal surgery on decreased visual acuity caused by pituitary apoplexy. Pituitary 13:154–159. doi:10.1007/s11102-009-0216-9
Seyer H, Kömpf D, Fahlbusch R (1992) Optomotor palsies in pituitary apoplexy. Neuro-Ophthalmol 12:217–224. doi:10.3109/01658109209058141
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors of this study have no conflict of interest.
Ethical approval
This study has been approved by the Ethical Committee of IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico. They all have given the permission for the publication of their clinical data.
Informed consent
All the patients included in this study have signed an informed consent form.
Rights and permissions
About this article
Cite this article
Giammattei, L., Mantovani, G., Carrabba, G. et al. Pituitary apoplexy: considerations on a single center experience and review of the literature. J Endocrinol Invest 39, 739–746 (2016). https://doi.org/10.1007/s40618-015-0424-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-015-0424-2